Back

Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation

27 August 2021 (20:15 - 20:24)
Organised by:
Congress Presentation Part of: Highlights from the Young in atrial fibrillation Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Jannis Dickow

Asklepios St. Georg Clinic, Hamburg (Germany)

3 More presentations in this session

Presentation thumbnail
Acute change in parasympathetic cardiac innervation after pulmonary vein isolation by pulse-field and radiofrequency energy
Doctor P. Stojadinovic (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
The association of stroke rate with low density lipoprotein and statin exposure in patients with atrial fibrillation (AF)
Doctor B. Shweikialrefaee (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
Doctor N. Habel (Burlington, US)
Abstract Slides Video

Access the full session

Session thumbnail
Highlights from the Young in atrial fibrillation

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 20:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources